Table 2.
Summary of comparisons between MEKARP and CSC
| MEK inhibitor associated retinopathy/pigment epitheliopathy (MEKARP) |
Central Serous Chorioretinopathy (CSC) |
|---|---|
| Bilateral in 92% | Up to 40% bilateral |
| Multifocal fluid foci (mean 6 foci per eye) | Unifocal or multifocal foci |
| 84% eyes with subfoveal focus, other foci conglomerate around the arcades | Foci in macula |
| Fluid foci have four configurations: dome, caterpillar, wavy or splitting | Fluid focus usually dome configuration |
| Fluid foci without gravitational dependency: shape of mercury globules | Fluid foci with gravitational dependency and inferior tracking of fluid |
| Fluid located in sub-interdigitation zone (IZ): between retinal pigment epithelium (RPE) and IZ | |
| No RPE detachments or intraretinal/choroidal hyperreflectile dots | Majority have RPE detachments or intraretinal/choroidal hyperreflectile dots |
| Elongation of IZ during fluid accumulation (38%) | |
| During fluid accumulation, IZ distinguishable from ellipzoid zone (EZ) and RPE | |
| Fluid accumulation makes IZ visible in eyes with indistinguishable IZ at baseline | |
| RPE, IZ and ellipsoid zone layers remain hyperreflectile and clearly distinguishable, both at the time of fluid accumulation and its resolution | IZ and EZ can become disturbed and may not reconstitute |
| Choroidal thickness normal and remains unchanged during fluid accumulation and resolution | Abnormally increased choroidal thickness in diseased and fellow eye |
| Symptoms include: blurry vision, metamorphopsia, dyschromatopsia | Symptoms include: blurry vision, metamorphopsia, dyschromatopsia |
| Majority of patients in this series are female (perhaps reflective of primary cancer diagnosis) | More common in male patients |